Replies to post #251627 on Biotech Values

[edcoolidge]

Jbog has become a complete clown.

Evolus licenses a toxin. They have no therapeutic program. They launched years before Daxxify. To compare expenses now is completely disingenuous. It's true Revance has overspent but they can and will cut expenses. If 3 years from now the situation hasn't changed then you will have been right—I doubt it.

Meanwhile, Daxxify is starting to blow up on social media.